CSX:NASDAQCSX Corporation Analysis
Data as of 2026-05-21 - not real-time
$45.94
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
CSX is trading just above its 20‑day SMA (≈45.28) and comfortably above the 50‑day SMA (≈42.68), confirming a bullish trend despite a marginally bearish MACD histogram. The RSI sits at 61.6, indicating solid momentum without being overbought, while the price hovers between the identified support (≈44.23) and resistance (≈46.74) zones. Volatility remains elevated at roughly 27% over the past 30 days, but a low beta (≈0.68) suggests limited market‑wide risk exposure.
Fundamentally, CSX delivers strong profitability with a 46.8% gross margin, 36.2% operating margin and a 21.5% net margin, and a high ROE of 23.7%. The forward P/E of 21.3 is notably lower than the current 28.2 and the industry average of 29.5, implying valuation upside, while the dividend yield of 1.22% and a modest payout ratio of 32% point to sustainable income. However, the balance sheet is levered, reflected in a debt‑to‑equity of 143% and a price‑to‑book of 6.29, which tempers the upside potential.
Fundamentally, CSX delivers strong profitability with a 46.8% gross margin, 36.2% operating margin and a 21.5% net margin, and a high ROE of 23.7%. The forward P/E of 21.3 is notably lower than the current 28.2 and the industry average of 29.5, implying valuation upside, while the dividend yield of 1.22% and a modest payout ratio of 32% point to sustainable income. However, the balance sheet is levered, reflected in a debt‑to‑equity of 143% and a price‑to‑book of 6.29, which tempers the upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance at $46.74
- Slightly bearish MACD histogram
- Stable dividend with low payout
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E of 21.3 vs current 28.2
- Strong cash flow generation
- Sustained dividend yield
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Durable rail infrastructure business
- Consistently high operating margins
- Long‑term earnings visibility despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin21.55%
P/E Ratio28.2
ROE23.68%
ROA7.08%
Debt/Equity143.06
P/B Ratio6.3
Op. Cash Flow$4.6B
Free Cash Flow$1.1B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI61.6
Support$44.23
Resistance$46.74
MA 20$45.28
MA 50$42.68
MA 200$37.91
MACDBearish
VolumeStable
Fear & Greed Index89.61
Valuation
Target Price$45.89
Upside/Downside-0.12%
GradeUndervalued
TypeValue
Dividend Yield1.22%
Risk Assessment
Beta0.68
Volatility26.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.